Russia’s Sputnik-5 vaccine will cost the government less than Pfizer and Moderna.
Moscow. Russia’s Sputnik-5 vaccine designed to fight the worldwide Kovid-19 epidemic will cost the government less than Pfizer and Moderna. The official Twitter handle of the world’s first registered vaccine gave this information on Sunday.
The tweet stated, “Pfizer’s declared price per dose is $ 19.50 (Rs. 1446.17) and Moderna is priced at $ 25 to $ 37 (Rs. 1854.07-2744.02), which means they are priced at $ 39 (according to a human being) 2892.34) and will cost 50 to 74 dollars (Rs 3708.13-5488.04). Every person will need two doses of Sputnik-5, Pfizer and Moderna. Sputnik-5 will cost much less than that. “
A Russian Direct Investment Fund (RDIF) spokesperson quoted the Tass news agency as saying in its report, the price of the Russian vaccine will be made public next week. When Sputnik-5 was officially registered before a large-scale clinical trial, Russia became the first country to give regulatory approval to the Kovid-19 vaccine in August. The vaccine has been developed jointly by the Gamalia National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF).